Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Guided Therapeutics has entered into a collaborative option to license and no shop agreement with Konica Minolta Opto, of Tokyo.
Subscribe to our email newsletter
Under terms of the agreement, Konica Minolta Opto (KMOT) will have a defined period of time to evaluate certain applications of Guided Therapeutics’s (GT’s) technology, including the potential adaptation of its LightTouch non-invasive cervical cancer detection technology to lung and biliary cancer. KMOT also will purchase prototype equipment and single use disposables.
Mark Faupel, president and CEO of GT, said: “The potential extension of our platform LightTouch technology into lung cancer detection may have a significant impact on this deadly cancer, which currently lacks cost effective and accurate methods for early detection.”